Anna Gilmore

11.3k total citations · 2 hit papers
232 papers, 7.1k citations indexed

About

Anna Gilmore is a scholar working on Organizational Behavior and Human Resource Management, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna Gilmore has authored 232 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Organizational Behavior and Human Resource Management, 107 papers in Physiology and 48 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anna Gilmore's work include Global Public Health Policies and Epidemiology (135 papers), Smoking Behavior and Cessation (106 papers) and Obesity, Physical Activity, Diet (27 papers). Anna Gilmore is often cited by papers focused on Global Public Health Policies and Epidemiology (135 papers), Smoking Behavior and Cessation (106 papers) and Obesity, Physical Activity, Diet (27 papers). Anna Gilmore collaborates with scholars based in United Kingdom, United States and South Africa. Anna Gilmore's co-authors include Gary Fooks, Martin McKee, Jeff Collin, Emily Savell, Ann McNeill, Katherine E. Smith, J Robert Branston, Sarah Lewis, Jenny Hatchard and Selda Ulucanlar and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anna Gilmore

222 papers receiving 6.8k citations

Hit Papers

Commercial determinants of health: future directions 2023 2026 2024 2025 2023 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Commercial determinants of health: future directions
    2023 90 citations Anna Gilmore, Mélissa Mialon et al. The Lancet profile →
  2. Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations
    2023 60 citations Jennifer Lacy‐Nichols, Sulakshana Nandi et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Gilmore United Kingdom 48 3.3k 3.0k 1.7k 1.5k 808 232 7.1k
Gerard Hastings United Kingdom 48 1.3k 0.4× 3.3k 1.1× 2.2k 1.3× 1.4k 0.9× 446 0.6× 196 9.0k
Kenneth E. Warner United States 57 1.1k 0.3× 4.7k 1.6× 2.7k 1.6× 2.3k 1.5× 888 1.1× 230 11.0k
Simon Chapman Australia 36 1.1k 0.3× 2.5k 0.8× 1.1k 0.6× 1.0k 0.7× 428 0.5× 213 5.4k
Melanie Wakefield Australia 64 1.6k 0.5× 7.2k 2.4× 4.8k 2.8× 2.2k 1.4× 1.1k 1.3× 364 15.8k
Ruth E. Malone United States 36 893 0.3× 1.9k 0.6× 668 0.4× 926 0.6× 241 0.3× 153 4.0k
James F. Thrasher United States 48 876 0.3× 6.5k 2.2× 3.0k 1.8× 872 0.6× 441 0.5× 404 9.0k
Amanda Amos United Kingdom 40 647 0.2× 3.9k 1.3× 1.6k 1.0× 1.4k 0.9× 1.0k 1.3× 141 6.6k
Marc Suhrcke United Kingdom 45 794 0.2× 815 0.3× 2.6k 1.5× 3.7k 2.4× 1.9k 2.4× 186 9.2k
K. Michael Cummings United States 67 1.1k 0.3× 11.7k 3.9× 4.8k 2.8× 1.4k 0.9× 884 1.1× 386 15.8k
Emmanuela Gakidou United States 45 803 0.2× 865 0.3× 1.2k 0.7× 2.3k 1.5× 1.2k 1.5× 113 8.2k

Countries citing papers authored by Anna Gilmore

Since Specialization
Citations

This map shows the geographic impact of Anna Gilmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gilmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gilmore more than expected).

Fields of papers citing papers by Anna Gilmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gilmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gilmore. The network helps show where Anna Gilmore may publish in the future.

Co-authorship network of co-authors of Anna Gilmore

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gilmore. A scholar is included among the top collaborators of Anna Gilmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gilmore. Anna Gilmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fabbri, Alice, et al.. (2025). Developing and evaluating an educational intervention on conflicts of interest and corporate influence on science. Health Promotion International. 40(3). 1 indexed citations
2.
3.
Bertscher, Adam, Britta Matthes, James Nobles, et al.. (2024). Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy. International Journal of Health Policy and Management. 13. 8033–8033. 1 indexed citations
4.
Fabbri, Alice, Adam Bertscher, Anna Gilmore, et al.. (2024). Industry influence on public health policy formulation in the UK: a complex systems approach. Health Promotion International. 39(6). 5 indexed citations
5.
Gilmore, Anna, et al.. (2024). Aligning rhetoric with reality: a qualitative analysis of multistakeholder initiatives in the global food system. Health Promotion International. 39(6). 1 indexed citations
6.
Gilmore, Anna, et al.. (2024). “Keep it a secret”: Leaked Documents Suggest Philip Morris International, and Its Japanese Affiliate, Continue to Exploit Science for Profit. Nicotine & Tobacco Research. 27(5). 794–804. 6 indexed citations
7.
Branston, J Robert, et al.. (2023). How has the tobacco industry passed tax changes through to consumers in 12 sub-Saharan African countries?. Tobacco Control. 34(1). 48–58. 1 indexed citations
8.
Alebshehy, Raouf, et al.. (2023). Exploring and monitoring the tobacco industry in the United Kingdom: the UK Tobacco Industry Interference Index. Journal of Health Inequalities. 9(2). 133–133. 1 indexed citations
9.
Matthes, Britta, Raouf Alebshehy, & Anna Gilmore. (2023). “They try to suppress us, but we should be louder”: a qualitative exploration of intimidation in tobacco control. Globalization and Health. 19(1). 88–88. 4 indexed citations
10.
11.
Matthes, Britta, et al.. (2023). Tobacco industry interference to undermine the development and implementation of graphic health warnings in Bangladesh. Tobacco Control. 33(5). 587–595. 2 indexed citations
12.
Lacy‐Nichols, Jennifer, Sulakshana Nandi, Mélissa Mialon, et al.. (2023). Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations. The Lancet. 401(10383). 1214–1228. 60 indexed citations breakdown →
13.
14.
Matthes, Britta, et al.. (2022). ’To be honest, I’m really scared’: perceptions and experiences of intimidation in the LMIC-based tobacco control community. Tobacco Control. 33(1). 38–44. 9 indexed citations
15.
Hatchard, Jenny, et al.. (2021). The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice. PLoS ONE. 16(6). e0253272–e0253272. 77 indexed citations
16.
Matthes, Britta, Kathrin Lauber, Mateusz Zatoński, Lindsay Robertson, & Anna Gilmore. (2021). Developing more detailed taxonomies of tobacco industry political activity in low-income and middle-income countries: qualitative evidence from eight countries. BMJ Global Health. 6(3). e004096–e004096. 31 indexed citations
17.
Gilmore, Anna, et al.. (2021). Paying lip service to publication ethics: scientific publishing practices and the Foundation for a Smoke-Free World. Tobacco Control. 30(e1). e65–e72. 21 indexed citations
18.
Matthes, Britta, Lindsay Robertson, & Anna Gilmore. (2020). Needs of LMIC-based tobacco control advocates to counter tobacco industry policy interference: insights from semi-structured interviews. BMJ Open. 10(11). e044710–e044710. 22 indexed citations
19.
Hiscock, Rosemary, et al.. (2020). Tobacco industry tactics to circumvent and undermine the menthol cigarette ban in the UK. Tobacco Control. 29(e1). tobaccocontrol–2020. 42 indexed citations
20.
Gilmore, Anna. (2005). TOBACCO AND TRANSITION: UNDERSTANDING THE IMPACT OF TRANSITION ON TOBACCO USE AND CONTROL IN THE FORMER SOVIET UNION. Tobacco Control. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerard Hastings Breakdown of academic impact, for papers by Kenneth E. Warner Breakdown of academic impact, for papers by Simon Chapman Breakdown of academic impact, for papers by Melanie Wakefield Breakdown of academic impact, for papers by Ruth E. Malone Breakdown of academic impact, for papers by James F. Thrasher Breakdown of academic impact, for papers by Amanda Amos Breakdown of academic impact, for papers by Marc Suhrcke Breakdown of academic impact, for papers by K. Michael Cummings Breakdown of academic impact, for papers by Emmanuela Gakidou
Rankless by CCL
2026